Kevin Tang - Jan 12, 2022 Form 4 Insider Report for LA JOLLA PHARMACEUTICAL CO (LJPC)

Role
Director, 10%+ Owner
Signature
/s/ Kevin Tang
Stock symbol
LJPC
Transactions as of
Jan 12, 2022
Transactions value $
$0
Form type
4
Date filed
1/14/2022, 03:05 PM
Previous filing
Dec 1, 2021
Next filing
Aug 24, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LJPC Stock Option (Right to Buy) Award $0 +30K $0.00 30K Jan 12, 2022 Common Stock 30K $4.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest and become exercisable on January 12, 2023, subject to the Reporting Person's continued service to the Issuer through such date.